The Global Image Guided Systems Market was valued at US$ 7.23 Billion in 2022 and is expected to reach US$ 17.41 Billion by 2033. The devices segment with a market share more than 75% has topped the global market within the product category and is expected to grow at a CAGR of close to 8.2% over the forecast period (2023 to 2033).
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 7.23 Billion |
| Market Value 2023 | US$ 7.79 Billion |
| Market Value 2033 | US$ 17.41 Billion |
| CAGR 2023 to 2033 | 8.4% |
| Share of Top 5 Countries | 63.4% |
| Key Players | Siemens Healthineers; Analogic Corporation; GE Healthcare; Koninklijke Philips N.V.; Stryker Corporation; Carestream Health; Hitachi Medical Corporation; Hologic; United Imaging Technologies Inc.; BrainLab AG; Karl Storz Gmbh & Co. Kg; Smith & Nephew Plc; Esaote SpA; Zimmer Biomet; Varian Medical Systems; Inc.; Medtronic Plc.; EndoMed Systems; Maxer Endoscopy; Blazejewski MEDI-TECH GmbH; Olympus Corporation; FUJIFILM Holdings Corporation; Shenyang Shenda Endoscope Co.; Ltd.; Shimadzu Corporation; Shenzhen Anke High-tech Co.; Ltd. |
Image guided surgery (IGS) refers to the application of a real-time correlation of the surgical field to a preoperative imaging data collection that reflects the precise placement of a chosen surgical instrument to the adjacent anatomic structures. Since the development of the endoscopic approach in the middle of the 1980s, image guided surgery has been one of the most important developments in endoscopic approach surgery.
Conventional surgical techniques take longer, are less precise, and include a risk of injury to neighboring nonsurgical areas. As a result, there is a rising need for surgical methods that are more accurate and quick. The benefits of image guided surgery devices include reduced damage, quicker healing of surgical wounds, and higher levels of accuracy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the image guided systems market grew at a CAGR of 7.7% between 2017 and 2022. Image guided systems market contributes 1.4% revenue share to the global medical device market, which is valued at US$ 512.6 Billion in 2022.
Imaging-guided systems are in demand because they provide physicians and other medical professionals with more accurate and precise information during medical procedures. By using imaging technologies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or X-rays, physicians can visualize the internal organs, tissues, and other structures of the body in real time. The technology can help physicians in various ways such as improved accuracy, reduced risk, and enhanced treatment planning which is accelerating the market growth for image guided systems.
Similarly, as a result of technological advancements, there is a greater demand worldwide for image guided systems. Minimally invasive surgeries provide a much faster recovery period and significantly less scarring than more invasive procedures. The rise in brain illnesses, orthopedic conditions, and trauma injuries is another element influencing the market expansion for image-guided surgical equipment.
Considering this, FMI expects the global market to grow at a CAGR of 8.4% through the forecasted years.
There is a growing preference for minimally invasive procedures over traditional open surgeries due to their advantages, including reduced scarring, shorter hospital stays, faster recovery times, and lower risk of complications. Image guided systems play a crucial role in guiding and monitoring minimally invasive interventions, ensuring precise targeting and safe delivery of treatments. The increasing adoption of minimally invasive procedures propels the demand for image guided systems.
The increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, has led to a rise in the demand for precise diagnosis, treatment planning, and minimally invasive interventions. Image guided systems offer improved visualization and guidance during procedures, enabling better disease management and patient outcomes.
The rising incidence of cardiovascular diseases (CVDs) and cancer is boosting market growth. CVDs and cancer are usually acute events that comprise the highest death rate in the world. For instance, the global burden of chronic diseases is escalating, with Cardiovascular Diseases (CVDs) responsible for around 32% of the 17.9 million deaths reported by the World Health Organization (WHO) in 2019.
These drivers collectively contribute to the growth and development of the image guided systems market, creating opportunities for technological advancements, market expansion, and improved patient care.
Principal Consultant
While the demand for imaging-guided systems continues to grow, there are also several market restraints that affect the adoption and growth of these systems.
Imaging-guided systems are often expensive to develop, purchase, and maintain. This high cost can limit their adoption, especially in developing countries with limited healthcare budgets. Moreover, in some regions, healthcare facilities may not have access to advanced imaging technologies, which can limit the adoption and use of imaging guided systems.
Regulations can limit the adoption of imaging guided systems in several ways. The approval process of IGS can be lengthy and complex which limits the adoption of these systems. These regulatory challenges can limit the adoption of imaging-guided systems, but they are necessary to ensure patient safety and to maintain high standards of care. Efforts are underway to streamline regulatory processes and to make imaging-guided systems more accessible and affordable for healthcare facilities.
The USA dominated the global market in 2022 and is expected to register a CAGR of 7.5% during the forecast period.
The expansion of the market is being driven by an increase in traumatic brain injuries (TBI) in the nation. In the USA, the prevalence of TBI tumors is increasing, and surgery is one of the management options for TBIs. The Centres for Disease Control and Prevention estimate that there were 69,473 TBI-related fatalities in 2021 and 223,135 hospitalizations due to TBI in 2019.
The USA has a robust healthcare and medical technology sector that fosters the development and adoption of advanced image guided systems. USA companies invest significantly in research and development, leading to the creation of cutting-edge technologies and products.
Germany dominated the European market for image guided systems and accounted for around 7.1% of the market share in 2022.
The development of endoscopic technology, mergers and acquisitions among major market participants, and the introduction of new products are mostly to influence the rise of the German market for Image guided systems.
For instance, Fujifilm introduced ColoAssist PRO, a real-time endoscopic visualization system, in Germany in November 2021. Also, Erbe Elektromedizia also bought Maxer Endoscopy, a Germany-based company, in April 2021 to expand its presence in this region. Therefore, due to the increase in product acceptance, product launches and acquisitions for the expansion of endoscopy services in Germany are anticipated to fuel market growth.
China accounted for revenue share of 4.7% in the global market at the end of 2022. China is projected to be the most attractive market over the forecast period.
According to a research report titled "Cardiovascular Potential Risk Factor and Disease Mortality in China" released in April 2022, the primary contributor to the cost of healthcare is cardiovascular disease (CVD). Furthermore, due to better clinical outcomes, quick recovery, and overall lower cost of minimally invasive surgeries compared to open surgeries, demand for image guided surgery is rising in the nation.
As a result, it is becoming increasingly apparent that people prefer less invasive surgeries will drive the market of image-guided surgery devices during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The devices segment held a market share of around 75.5% of the global market by the end of 2022.
The aspect which is promoting business growth is the demand for minimally invasive therapies. According to a statewide survey study by Johns Hopkins Medicine, the use of minimally invasive procedures for several common operations can reduce postoperative complications and can also save healthcare costs. As a result of the increased demand for less intrusive image-guided treatments, the market is expected to expand in the near future.
The neurosurgery segment accounted for a revenue share of 29.3% in the global market at the end of 2022.
Neurosurgery involves intricate procedures within the brain and nervous system, requiring a high level of precision. Image guided systems provide real-time visualization and navigation tools that enable surgeons to accurately target and navigate through delicate neural structures. Also, the increasing prevalence of these conditions has led to a higher demand for neurosurgical interventions, driving the growth of the image guided systems market in the neurosurgery segment.
The hospital’s segment accounted for a revenue share of 74.8% in the global market at the end of 2022.
Hospitals provide easy access to treatment alternatives, with many offering technologically advanced Image guided systems for a variety of ailments such as urology and oncology surgeries.
Overall, hospitals provide quick and accessible treatment choices for a wide range of chronic illnesses, making them the most popular segment for these treatments.
Key image guided system market companies are investing substantial resources in new product innovation, providing unique equipment to treat patients, and providing life-sustaining treatment. Some major businesses are acquiring other companies in order to strengthen their global market positions, while others are focusing on product launches.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the image guided systems market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries |
| Key Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Siemens Healthineers; Analogic Corporation; GE Healthcare; Koninklijke Philips N.V.; Stryker Corporation; Carestream Health; Hitachi Medical Corporation; Hologic; United Imaging Technologies Inc.; BrainLab AG; Karl Storz Gmbh & Co. Kg; Smith & Nephew Plc; Esaote SpA; Zimmer Biomet; Varian Medical Systems, Inc.; Medtronic Plc.; EndoMed Systems; Maxer Endoscopy; Blazejewski MEDI-TECH GmbH; Olympus Corporation; FUJIFILM Holdings Corporation; Shenyang Shenda Endoscope Co., Ltd.; Shimadzu Corporation; Shenzhen Anke High-tech Co., Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is expected to reach US$ 17.41 billion by 2033
The market is projected to record a CAGR of 8.4% through 2033.
Siemens Healthineers, Carestream Health, and Medtronic Plc. are some key players.
The medical imaging segment is leading in the image guided systems market.
Integration of artificial intelligence for image analysis and the use of image guided systems in minimally invasive techniques.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Installed Base Scenario, By Key Countries 4.3. Product Features/ USPs 4.4. PESTEL Analysis 4.5. Porter’s Analysis 4.6. Regulatory Landscape 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Life Expectancy Outlook 5.1.4. Global Medical Devices Market (Parent Market Analysis) 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Growing Geriatric Population Rate 5.2.3. Growing use of image-guided surgery equipment 5.2.4. Rising Healthcare Spending 5.2.5. Technological Advancement 5.2.6. Increasing Prevalence of Chronic Diseases 5.2.7. Surge in Minimally Invasive Surgeries 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Application 6.1.3. By End User 6.1.4. By Region 6.2. 2023 Market Scenario 7. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7.1. Historical Volume (in Units) Analysis, 2017 to 2022 7.2. Current and Future Volume (in Units) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 10.3.1. Device 10.3.1.1. Computed Tomography (CT) Scanners 10.3.1.2. Ultrasound Systems 10.3.1.3. Magnetic Resonance Imaging (MRI) 10.3.1.4. Endoscopes 10.3.1.5. X-ray Fluoroscopy 10.3.1.6. Positron Emission Tomography (PET) 10.3.1.7. Single Photon Emission Computed Tomography (SPECT) 10.3.2. Software 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 11.3.1. Cardiac Surgery 11.3.2. Neurosurgery 11.3.3. Orthopedic Surgery 11.3.4. Gastroenterology 11.3.5. Urology 11.3.6. Oncology Surgery 11.3.7. Others (ENT, Dental, Pulmonary surgery 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Clinics 12.3.4. Research & Academic Institutes 12.4. Market Attractiveness Analysis By Application 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. The USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Country Level Analysis & Forecast 14.5.1. USA Market Analysis 14.5.1.1. .Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Application 14.5.1.2.3. By End User 14.5.2. Canada Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Application 14.5.2.2.3. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Country Level Analysis & Forecast 15.5.1. Brazil Market Analysis 15.5.1.1. .Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Application 15.5.1.2.3. By End User 15.5.2. Mexico Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Application 15.5.2.2.3. By End User 15.5.3. Argentina Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Application 15.5.3.2.3. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. France 16.3.1.3. Italy 16.3.1.4. United Kingdom 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Rest of Europe 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Country Level Analysis & Forecast 16.5.1. Germany Market Analysis 16.5.1.1. .Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Application 16.5.1.2.3. By End User 16.5.2. France Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Application 16.5.2.2.3. By End User 16.5.3. Italy Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Application 16.5.3.2.3. By End User 16.5.4. United Kingdom Market Analysis 16.5.4.1. .Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Application 16.5.4.2.3. By End User 16.5.5. Spain Market Analysis 16.5.5.1. .Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Product 16.5.5.2.2. By Application 16.5.5.2.3. By End User 16.5.6. Russia Market Analysis 16.5.6.1. .Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Product 16.5.6.2.2. By Application 16.5.6.2.3. By End User 16.5.7. BENELUX Market Analysis 16.5.7.1. .Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Product 16.5.7.2.2. By Application 16.5.7.2.3. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Country Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. .Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Application 17.5.1.2.3. By End User 17.5.2. Thailand Market Analysis 17.5.2.1. .Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Application 17.5.2.2.3. By End User 17.5.3. Indonesia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Application 17.5.3.2.3. By End User 17.5.4. Malaysia Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product 17.5.4.2.2. By Application 17.5.4.2.3. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By End User 18.5. Country Level Analysis & Forecast 18.5.1. China Market Analysis 18.5.1.1. .Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Application 18.5.1.2.3. By End User 18.5.2. Japan Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Application 18.5.2.2.3. By End User 18.5.3. South Korea Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Application 18.5.3.2.3. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By End User 19.5. Country Level Analysis & Forecast 19.5.1. Australia Market Analysis 19.5.1.1. .Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Application 19.5.1.2.3. By End User 19.5.2. New Zealand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Application 19.5.2.2.3. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Application 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Application 20.4.4. By End User 20.5. Country Level Analysis & Forecast 20.5.1. GCC Countries Market Analysis 20.5.1.1. .Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product 20.5.1.2.2. By Application 20.5.1.2.3. By End User 20.5.2. Türkiye Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product 20.5.2.2.2. By Application 20.5.2.2.3. By End User 20.5.3. Northern Africa Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product 20.5.3.2.2. By Application 20.5.3.2.3. By End User 20.5.4. South Africa Market Analysis 20.5.4.1. Introduction 20.5.4.2. Market Analysis and Forecast by Market Taxonomy 20.5.4.2.1. By Product 20.5.4.2.2. By Application 20.5.4.2.3. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Siemens Healthineers 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Key Financials 22.3.1.4. Sales Footprint 22.3.1.5. SWOT Analysis 22.3.1.6. Key Developments 22.3.1.7. Strategy Overview 22.3.1.7.1. Marketing Strategy 22.3.1.7.2. Product Strategy 22.3.1.7.3. Channel Strategy 22.3.2. Analogic Corporation 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Key Financials 22.3.2.4. Sales Footprint 22.3.2.5. SWOT Analysis 22.3.2.6. Key Developments 22.3.2.7. Strategy Overview 22.3.2.7.1. Marketing Strategy 22.3.2.7.2. Product Strategy 22.3.2.7.3. Channel Strategy 22.3.3. GE Healthcare 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Key Financials 22.3.3.4. Sales Footprint 22.3.3.5. SWOT Analysis 22.3.3.6. Key Developments 22.3.3.7. Strategy Overview 22.3.3.7.1. Marketing Strategy 22.3.3.7.2. Product Strategy 22.3.3.7.3. Channel Strategy 22.3.4. Koninklijke Philips N.V. 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Key Financials 22.3.4.4. Sales Footprint 22.3.4.5. SWOT Analysis 22.3.4.6. Key Developments 22.3.4.7. Strategy Overview 22.3.4.7.1. Marketing Strategy 22.3.4.7.2. Product Strategy 22.3.4.7.3. Channel Strategy 22.3.5. Stryker Corporation 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Key Financials 22.3.5.4. Sales Footprint 22.3.5.5. SWOT Analysis 22.3.5.6. Key Developments 22.3.5.7. Strategy Overview 22.3.5.7.1. Marketing Strategy 22.3.5.7.2. Product Strategy 22.3.5.7.3. Channel Strategy 22.3.6. Carestream Health 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Key Financials 22.3.6.4. Sales Footprint 22.3.6.5. SWOT Analysis 22.3.6.6. Key Developments 22.3.6.7. Strategy Overview 22.3.6.7.1. Marketing Strategy 22.3.6.7.2. Product Strategy 22.3.6.7.3. Channel Strategy 22.3.7. Hitachi Medical Corporation 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Key Financials 22.3.7.4. Sales Footprint 22.3.7.5. SWOT Analysis 22.3.7.6. Key Developments 22.3.7.7. Strategy Overview 22.3.7.7.1. Marketing Strategy 22.3.7.7.2. Product Strategy 22.3.7.7.3. Channel Strategy 22.3.8. Hologic 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Key Financials 22.3.8.4. Sales Footprint 22.3.8.5. SWOT Analysis 22.3.8.6. Key Developments 22.3.8.7. Strategy Overview 22.3.8.7.1. Marketing Strategy 22.3.8.7.2. Product Strategy 22.3.8.7.3. Channel Strategy 22.3.9. United Imaging Technologies Inc. 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Key Financials 22.3.9.4. Sales Footprint 22.3.9.5. SWOT Analysis 22.3.9.6. Key Developments 22.3.9.7. Strategy Overview 22.3.9.7.1. Marketing Strategy 22.3.9.7.2. Product Strategy 22.3.9.7.3. Channel Strategy 22.3.10. BrainLab AG 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Key Financials 22.3.10.4. Sales Footprint 22.3.10.5. SWOT Analysis 22.3.10.6. Key Developments 22.3.10.7. Strategy Overview 22.3.10.7.1. Marketing Strategy 22.3.10.7.2. Product Strategy 22.3.10.7.3. Channel Strategy 22.3.11. Karl Storz Gmbh & Co. Kg 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Key Financials 22.3.11.4. Sales Footprint 22.3.11.5. SWOT Analysis 22.3.11.6. Key Developments 22.3.11.7. Strategy Overview 22.3.11.7.1. Marketing Strategy 22.3.11.7.2. Product Strategy 22.3.11.7.3. Channel Strategy 22.3.12. Smith & Nephew Plc 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Key Financials 22.3.12.4. Sales Footprint 22.3.12.5. SWOT Analysis 22.3.12.6. Key Developments 22.3.12.7. Strategy Overview 22.3.12.7.1. Marketing Strategy 22.3.12.7.2. Product Strategy 22.3.12.7.3. Channel Strategy 22.3.13. Esaote SpA 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Key Financials 22.3.13.4. Sales Footprint 22.3.13.5. SWOT Analysis 22.3.13.6. Key Developments 22.3.13.7. Strategy Overview 22.3.13.7.1. Marketing Strategy 22.3.13.7.2. Product Strategy 22.3.13.7.3. Channel Strategy 22.3.14. Zimmer Biomet 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Key Financials 22.3.14.4. Sales Footprint 22.3.14.5. SWOT Analysis 22.3.14.6. Key Developments 22.3.14.7. Strategy Overview 22.3.14.7.1. Marketing Strategy 22.3.14.7.2. Product Strategy 22.3.14.7.3. Channel Strategy 22.3.15. Varian Medical Systems, Inc. 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Key Financials 22.3.15.4. Sales Footprint 22.3.15.5. SWOT Analysis 22.3.15.6. Key Developments 22.3.15.7. Strategy Overview 22.3.15.7.1. Marketing Strategy 22.3.15.7.2. Product Strategy 22.3.15.7.3. Channel Strategy 22.3.16. Medtronic Plc. 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Key Financials 22.3.16.4. Sales Footprint 22.3.16.5. SWOT Analysis 22.3.16.6. Key Developments 22.3.16.7. Strategy Overview 22.3.16.7.1. Marketing Strategy 22.3.16.7.2. Product Strategy 22.3.16.7.3. Channel Strategy 22.3.17. EndoMed Systems 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Key Financials 22.3.17.4. Sales Footprint 22.3.17.5. SWOT Analysis 22.3.17.6. Key Developments 22.3.17.7. Strategy Overview 22.3.17.7.1. Marketing Strategy 22.3.17.7.2. Product Strategy 22.3.17.7.3. Channel Strategy 22.3.18. Maxer Endoscopy 22.3.18.1. Overview 22.3.18.2. Product Portfolio 22.3.18.3. Key Financials 22.3.18.4. Sales Footprint 22.3.18.5. SWOT Analysis 22.3.18.6. Key Developments 22.3.18.7. Strategy Overview 22.3.18.7.1. Marketing Strategy 22.3.18.7.2. Product Strategy 22.3.18.7.3. Channel Strategy 22.3.19. Blazejewski MEDI-TECH GmbH 22.3.19.1. Overview 22.3.19.2. Product Portfolio 22.3.19.3. Key Financials 22.3.19.4. Sales Footprint 22.3.19.5. SWOT Analysis 22.3.19.6. Key Developments 22.3.19.7. Strategy Overview 22.3.19.7.1. Marketing Strategy 22.3.19.7.2. Product Strategy 22.3.19.7.3. Channel Strategy 22.3.20. Olympus Corporation 22.3.20.1. Overview 22.3.20.2. Product Portfolio 22.3.20.3. Key Financials 22.3.20.4. Sales Footprint 22.3.20.5. SWOT Analysis 22.3.20.6. Key Developments 22.3.20.7. Strategy Overview 22.3.20.7.1. Marketing Strategy 22.3.20.7.2. Product Strategy 22.3.20.7.3. Channel Strategy 22.3.21. FUJIFILM Holdings Corporation 22.3.21.1. Overview 22.3.21.2. Product Portfolio 22.3.21.3. Key Financials 22.3.21.4. Sales Footprint 22.3.21.5. SWOT Analysis 22.3.21.6. Key Developments 22.3.21.7. Strategy Overview 22.3.21.7.1. Marketing Strategy 22.3.21.7.2. Product Strategy 22.3.21.7.3. Channel Strategy 22.3.22. Shenyang Shenda Endoscope Co., Ltd. 22.3.22.1. Overview 22.3.22.2. Product Portfolio 22.3.22.3. Key Financials 22.3.22.4. Sales Footprint 22.3.22.5. SWOT Analysis 22.3.22.6. Key Developments 22.3.22.7. Strategy Overview 22.3.22.7.1. Marketing Strategy 22.3.22.7.2. Product Strategy 22.3.22.7.3. Channel Strategy 22.3.23. Shimadzu Corporation 22.3.23.1. Overview 22.3.23.2. Product Portfolio 22.3.23.3. Key Financials 22.3.23.4. Sales Footprint 22.3.23.5. SWOT Analysis 22.3.23.6. Key Developments 22.3.23.7. Strategy Overview 22.3.23.7.1. Marketing Strategy 22.3.23.7.2. Product Strategy 22.3.23.7.3. Channel Strategy 22.3.24. Shenzhen Anke High-tech Co., Ltd. 22.3.24.1. Overview 22.3.24.2. Product Portfolio 22.3.24.3. Key Financials 22.3.24.4. Sales Footprint 22.3.24.5. SWOT Analysis 22.3.24.6. Key Developments 22.3.24.7. Strategy Overview 22.3.24.7.1. Marketing Strategy 22.3.24.7.2. Product Strategy 22.3.24.7.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Healthcare
January 2022
REP-GB-1333
January 2023
333 pages
Explore Healthcare Insights
View Reports
Image Guided Systems Market
